Sucampo's glaucoma drug Rescula wins FDA clearance

12/13/2012 | American City Business Journals

The FDA approved the use of Sucampo Pharmaceuticals' Rescula, or unoprostone isopropyl, for intraocular pressure reduction in patients with ocular hypertension or open-angle glaucoma. Sucampo plans to launch the drug in the first quarter.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President, Science and Regulatory Affairs
American Beverage Association
Washington, DC
Senior Manager of Medical Management
Network Health
Medford, MA
MEDICAL SCIENCE LIAISON - 14000002RO
Abbott
Columbus, OH
Manager, Medical Management
Network Health
Medford, MA
Medical Director - Cataract
Abbott
Santa Ana, CA